TABLE 1.
N | Age | Gender | Stroke lesion | Affected hemisphere | Months from stroke | NIHSS | GPFT | RMT AH | RMT UH |
---|---|---|---|---|---|---|---|---|---|
1 | 70 | F | F–T, Ins | L | 6 | 7 | n.a. | 66 | 74 |
2 | 74 | F | CN, CR | R | 6 | 9 | n.a. | n.e. | 75 |
3 | 61 | F | F–P | L | 13 | 7 | −45.2 | n.e. | 54 |
4 | 50 | F | CN | R | 7 | 7 | −49.5 | n.e. | 65 |
5 | 79 | F | Ins‐T–P–CN | R | 10 | 6 | n.a. | 89 | 81.5 |
6 | 44 | F | T‐ins | R | 14 | 7 | −43.7 | n.e. | 56 |
7 | 40 | F | SC, CR | L | 7 | 4 | −4.7 | 63 | 72 |
8 | 61 | M | F–T–P | L | 77 | 11 | n.a. | n.e. | 84 |
9 | 58 | M | F–T–P | R | 5 | 2 | −15.45 | 86 | 59 |
10 | 64 | M | F–P, Ins, CR, BG | L | 12 | 8 | −107.2 | n.e. | 56 |
11 | 54 | M | F–T–P, LN, IC | R | 13 | 4 | −23.3 | 60 | 49 |
12 | 64 | M | CR, EC | L | 6 | 8 | −25 | 60 | 57.5 |
13 | 59 | M | F–T–P | R | 7 | 10 | −63.3 | n.e. | 56 |
14 | 67 | M | F–T–P | R | 24 | 5 | n.a. | 71.5 | 58 |
15 | 62 | M | F‐Ins, P–O, PUT | R | 6 | 10 | n.a. | n.e. | 86 |
16 | 62 | M | F–T–P | L | 7 | 4 | n.a. | 50 | 46 |
17 | 70 | M | F–P | R | 78 | 3 | −68.6 | 87 | 57 |
18 | 55 | M | CN | R | 6 | 4 | n.a. | 96 | 75 |
19 | 70 | M | F–P | R | 16 | 10 | n.a. | n.e. | 71.5 |
Note: Instrumental and neurophysiological data are averaged between the two time points (T0 and T1). RMT values refer to the ones collected in the cortical evaluation. Patients who underwent structural evaluation are highlighted in bold.
Abbreviations: AH, affected hemisphere; BG, basal ganglia; CN, capsular nucleus; CR, corona radiata; EC, external capsula; F, female; F–T–P–O, fronto–temporal–parietal–occipital; IC, internal capsula; Ins, Insula; LN, lenticular nucleus; M, male; mRS: modified Rankin Scale; NIHSS: National Institute of Health Stroke Scale; PUT, putamen; R, real‐TBS; RMT, resting motor threshold; S, sham‐TBS; SC, semioval center; UH, unaffected hemisphere.